A novel prognostic score for acute-on-chronic hepatitis B liver failure

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 35, Issue 1, 2015, Pages 87-92

  Yi, Zhao quan ^a   Lu, Meng hou ^a   Xu, Xu wen ^a   Fu, Xiao yu ^a   Tan, De ming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

acute on chronic liver failure; Child Turcotte Pugh score; hepatitis B; model for end stage liver disease score; prognosis; receiver operating characteristic

Indexed keywords

ACUTE DISEASE; ADULT; CHRONIC DISEASE; COMPLICATION; FEMALE; HEPATITIS B; HUMAN; LIVER FAILURE; MALE; MIDDLE AGED; PROGNOSIS;

ACUTE DISEASE; ADULT; CHRONIC DISEASE; FEMALE; HEPATITIS B; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84922566819     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-015-1394-5     Document Type: Article

References (18)

1. Katoonizadeh A, Laleman W, Verslype C, et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut, 2010,59(11):1561–1569
2. Brown RS Jr1, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl, 2002,8(3):278–284
3. He WP, Hu JH, Zhao J, et al. Comparison of four prognostic models and a new Logistic regression model to predict short-term prognosis of acute-on-chronic hepatitis B liver failure. Chin Med J (Engl), 2012,125(13):2272–2278
4. Magder LS, Regev A, Mindikoglu AL. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int, 2012,25(4):409–415
5. Graziadei IW. The clinical challenges of acute on chronic liver failure. Liver Int, 2011,31(Suppl 3):24–26
6. Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int, 2009,3(1):269–282
7. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology, 2003,124(1):91–96
8. Cai CJ, Chen HA, Lu MQ, et al. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B. Chin Med J (Engl), 2008,121(20):2065–2069
9. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology, 2006,130(6):1652–1660
10. Huo TI, Wang YW, Yang YY, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int, 2007,27(4): 498–506
11. Zhang QB, Chen YT, Lian GD, et al. A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis. Clin Res Hepatol Gastroenterol, 2012,36(6):583–591
12. Györi GP, Silberhumer GR, Zehetmayer S, et al. Dynamic changes in MELD score not only predict survival on the waiting list but also overall survival after liver transplantation. Transpl Int, 2012,25(9):935–940
13. Klibansky DA, Mehta SH, Curry M, et al. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat, 2012,19(2): e184–193
14. Cui YL, Yan F, Wang YB, et al. Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure. Dig Dis Sci, 2010,55(8):2373–2380
15. Sun QF, Ding JG, Xu DZ, et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model. J Viral Hepat, 2009,16(7):464–470
16. Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology, 2011,53(3):1020–1022
17. Liu Q, Liu Z, Wang T, et al. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. J Gastroenterol Hepatol, 2007,22(12): 2101–2106
18. Parkash O, Mumtaz K, Hamid S, et al. MELD score: utility and comparison with King’s College criteria in non-acetaminophen acute liver failure. J Coll Physicians Surg Pak, 2012,22(8):492–496